-
1 Comment
Apollo Hospitals Enterprise Limited is currently in a long term uptrend where the price is trading 31.5% above its 200 day moving average.
From a valuation standpoint, the stock is 18.5% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 3.9.
Apollo Hospitals Enterprise Limited's total revenue sank by 5.2% to $28B since the same quarter in the previous year.
Its net income has increased by 41.6% to $1B since the same quarter in the previous year.
Based on the above factors, Apollo Hospitals Enterprise Limited gets an overall score of 3/5.
ISIN | INE437A01024 |
---|---|
Sector | Healthcare |
Industry | Medical Care Facilities |
Exchange | NSE |
CurrencyCode | INR |
Market Cap | 1T |
---|---|
PE Ratio | 78.12 |
Target Price | 7779.3447 |
Dividend Yield | 0.3% |
Beta | 0.37 |
Apollo Hospitals Enterprise Limited, together with its subsidiaries, engages in the provision of healthcare services in India and internationally. It operates through Healthcare Services, Retail Health & Diagnostics, Digital Health & Pharmacy Distribution, and Others segments. The company's healthcare facilities comprise primary, secondary, and tertiary care, as well as specialty facilities. It offers services in cardiac sciences, orthopedics, oncology, neurosciences, emergency, robotic surgery, and transplants; and cardiology, neurology, gastroenterology, dermatology, ophthalmology, pediatric, endocrinology, gynecology, urology, nephrology, pulmonology, rheumatology, neurosurgery, radiology, plastic-surgery, neonatology, vascular-surgery, psychiatry, dentistry, ear, nose, and throat care, as well as genomic medicines. The company also provides other services, such as project consultancy, health insurance, medical colleges, medvarsity for e-learning, and research services. In addition, it operates pharmacies, primary care clinics, birthing centers, specialized birthing centers, dialysis centers, cradle and fertility centers, diabetes management centers, single specialty clinics, primary health centers and diagnostic chains, dental clinics, and daycare and home healthcare centers. Further, the company engages in the business of bio-banking of tissues. It serves through national retail healthcare centers and genomics institutes, as well as Apollo 24/7, a digital health mobile platform; and www.apollopharmacy.in, an online pharmacy. The company was incorporated in 1979 and is based in Chennai, India.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for APOLLOHOSP.NSE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025